Nanometer-sized “drones” that deliver a special type of healing molecule to fat deposits in arteries could become a new way to prevent heart attacks
Nanometer-sized “drones” that deliver a special type of healing molecule to fat deposits in arteries could become a new way to prevent heart attacks caused by atherosclerosis, according to a study in pre-clinical models by scientists at Brigham and Women’s Hospital (BWH) and Columbia University Medical Center. These findings are published in the February 18th online issue of Science Translational Medicine.
Although current treatments have reduced the number of deaths from atherosclerosis-related disease, atherosclerosis remains a dangerous health problem: Atherosclerosis of the coronary arteries is the #1 killer of women and men in the U.S., resulting in one out of every four deaths. In the study, targeted biodegradable nano ‘drones’ that delivered a special type of drug that promotes healing (‘resolution’) successfully restructured atherosclerotic plaques in mice to make them more stable. This remodeling of the plaque environment would be predicted in humans to block plaque rupture and thrombosis and thereby prevent heart attacks and strokes.
“This is the first example of a targeted nanoparticle technology that reduces atherosclerosis in an animal model,” said co-senior author Omid Farokhzad, MD, associate professor and director of the Laboratory of Nanomedicine and Biomaterials at BWH and Harvard Medical School (HMS). “Years of research and collaboration have culminated in our ability to use nanotechnology to resolve inflammation, remodel and stabilize plaques in a model of advanced atherosclerosis.”
In this study, targeted nanomedicines made from polymeric building blocks that are utilized in numerous FDA approved products to date, were nanoengineered to carry an anti-inflammatory drug payload in the form of a biomimetic peptide. Furthermore, this peptide was derived from one of the body’s own natural inflammatory-resolving proteins called Annexin A1. The way the nanomedicines were designed enabled this biological therapeutic to be released at the target site, the atherosclerotic plaque, in a controlled manner.
In mouse models with advanced atherosclerosis, researchers administered nanomedicines and relevant controls. Following five weeks of treatment with the nanomedicines, damage to the arteries was significantly repaired and plaque was stabilized.
Specifically, researchers observed a reduction of reactive oxygen species; increase in collagen, which strengthens the fibrous cap; and reduction of the plaque necrotic core, and these changes were not observed in comparison with the free peptide or empty nanoparticles.
“Many researchers are trying to develop drugs that prevent heart attacks by tamping down inflammation, but that approach has some downsides,” said co-senior author Ira Tabas, MD, Richard J. Stock professor of Medicine (Immunology) and professor of Pathology & Cell Biology at Columbia. “One is that atherosclerosis is a chronic disease, so drugs are taken for years, even decades. An anti-inflammatory drug that is distributed throughout the entire body will also impair the immune system’s ability to fight infection.” That might be acceptable for conditions that severely affect quality of life, like rheumatoid arthritis, but “using this approach to prevent a heart attack that may never happen may not be worth the risk.”
In addition, it’s not enough to deliver an anti-inflammatory drug to the plaques, said Columbia associate research scientist Gabrielle Fredman, PhD, one of the study’s lead co-authors. “Atherosclerosis is not only inflammation; there’s also damage to the arterial wall. If the damage isn’t repaired, you may not prevent heart attacks.”
The targeted nanomedicines used in this current study were engineered by researchers at BWH. Following preliminary proof-of-principle studies at Columbia University in models of inflammation, they were further tested in a clinically relevant disease model in mice and were shown to be capable of maneuvering through the blood circulation, and traversing leaky regions through to the inside of the plaques, as was demonstrated by fluorescence microscopy imaging of the plaque lesions.
Researchers note that in addition to their specific ‘sticky’ surfaces, their small sub-100 nanometer size is also a key property that facilitates the retention and accumulation of these nanoparticles within the plaques. These nanoparticles are 1000 times smaller than the tip of a single human-hair strand.
“These nanomedicines are developed using biodegradable polymers that can break-up over time in the body using the bodies natural mechanisms, and can be nanoengineered using scale-able chemistries and nanotechnologies, which ultimately can facilitate their rapid translation to the clinic,” said co-lead author Nazila Kamaly, PhD, instructor in the Laboratory of Nanomedicine and Biomaterials at BWH and HMS.
Researchers caution that although plaques in mice look a lot like human plaques, mice do not have heart attacks, so the real test of the nanoparticles will not come until they are tested in humans. “In this study, we’ve shown, for the first time, that a drug that promotes resolution of inflammation and repair is a viable option, when the drug is delivered directly to plaques via nanoparticles,” said Tabas. To be ready for testing in humans, the team plans to fine-tune the nanoparticles to optimize drug delivery and to package them with more potent resolution-inducing drugs. “We think that we can obtain even better delivery to plaques and improve healing more than with the current peptides,” , he said.
The Latest on: Nanodrones
via Google News
The Latest on: Nanodrones
- Commercial Drone Market Futuristic Comprehensive Insights Report [Forecast 2029] | AeroVironment Inc, 3D Robotics Incon November 26, 2020 at 12:37 pm
Fixed wing drones Rotary blade drones Nano drones Hybrid drones Download Now And Browse Complete Information On The COVID 19 Impact Analysis On Commercial Drone Market: https://marketresearch.biz ...
- Nano Drones Market Futuristic Comprehensive Insights with COVID-19 Impact Analysis AeroVironment inc., Parrot SA, JJRC Toyon November 26, 2020 at 1:43 am
Super Discount!! Grab Maximum up-to 25% off On Nano Drones Market Research Reports [Single User | Multi-User | Corporate Users] Valid Till 15 January 2021. The futuristic comprehensive insights of ...
- Small Drones Market Key Methodologies, Growth Rate and Future Opportunities, Forecast Till 2029 | 3D Robotics Inc and BAE SystemsIncon November 25, 2020 at 2:43 am
MarketResearch.Biz :Small Drones Market Overview: The report provides each quantitative and qualitative information on the global Small Drones market for the period of 2020 to 2029. Given the ...
- drone hackson November 24, 2020 at 4:00 pm
You’ve probably heard of micro-drones, perhaps even nano-drones, but there research institutions that shrink these machines down to the size of insects. Leading from the [Wiss Institute For ...
- The Cost of Lieson November 23, 2020 at 3:52 am
Fiction Contest Week This is a sequel to "At the Moral Level." By Major Ian Brown, USMC Now Jayna woke up and the river was on fire. Her mind throbbed ...
- Commercial Drone Market Strategic Industry Evolutionary Analysis Till 2029 | AeroVironment Inc, 3D Robotics Incon November 20, 2020 at 1:32 am
Global commercial drone market segmentation, by product type: Fixed wing drones Rotary blade drones Nano drones Hybrid drones Global commercial drone market segmentation, by applications ...
- Future of Drones in India: Draft Rules 2020on November 9, 2020 at 1:45 pm
The abovesaid exception pertaining to the reclassification of Nano Drones is likely to impact the current Drone ecosystem and pose a challenge for its manufactures and existing operators.
- Drones Soon To Be Used For Ecommerce Deliveries In India: Civil Aviation Ministryon November 1, 2020 at 4:00 pm
Nano drones, which weigh below 250 grams and are not equipped to fly more than 50 feet above the ground level are exempted from licensing and permission formalities. Unmanned aerial vehicles ...
- FLIR Systems, Inc. (FLIR) CEO Jim Cannon on Q3 2020 Results - Earnings Call Transcripton October 30, 2020 at 10:28 am
So it's really coming the growth from our unmanned systems. And there, as we've said on earlier calls, we've got small nano drones and aerial systems that are accretive to the overall business.
- SOCom is asking to see all kinds of drones, some for delivering blood to the battlefieldon September 4, 2018 at 2:08 am
Goers, a Tampa city planner and host of the streaming Drone Radio Show, said that of all SOCom's drone requests, the blood delivery system and so-called nano drones stand out. He said "the ability ...
via Bing News